08:45 |
Welcome Norbert Krug and Armin Braun, Fraunhofer ITEM |
Session 1: RNA therapeutics for lung disease Chair: Armin Braun, Fraunhofer ITEM |
|
09:00 |
Modulation of host immunity in the airways with interferon lambda encoding mRNA Christian Plank, Ethris (Germany) |
09:30 |
New approaches for therapeutic pulmonary RNA delivery Olivia Merkel, Ludwig-Maximilians-University of Munich (Germany) |
Session 2: Understanding and fighting infections Chair: Franziska Dahlmann, Fraunhofer ITEM |
|
10:00 |
Disrupting cellular metal homeostasis to break antibiotic resistance against drug-resistant bacterial pathogens Mark von Itzstein, Griffith University (Australia) |
10:30 |
Coffee break |
11:00 |
Small molecule inhibitors of hemolysin for the treatment of S. aureus lung infections Mark Brönstrup, Helmholtz Centre for Infection Research (HZI), Braunschweig (Germany) |
11:30 |
Bacterial lysates for preventing respiratory tract infections: Is it all about vaccination? Edouard Baulier, OM Pharma (Switzerland) |
12:00 |
Safety, reactogenicity and immunogenicity of a novel MVA-SARS-2-ST vaccine candidate administered as inhalation boost in SARS-CoV-2 immunized adults – current status Jens Hohlfeld, Fraunhofer ITEM |
12:30 | Respiratory infection: A “missing link” in the pathogenesis underlying COPD exacerbations and disease progression Alison Humbles, Roche (Switzerland) |
13:00 |
Lunch break |
Session 3: Drug delivery to airways and lung Chair: Jens Hohlfeld, Fraunhofer ITEM |
|
14:00 |
Delivering antibacterial therapeutics to the lung: Current challenges and opportunities? Sven Hobbie, University of Zurich (Switzerland) |
14:30 |
Improving drug delivery to the lung Gerhard Pohlmann, Fraunhofer ITEM |
15:00 |
Pharmaceutical development of biological molecules with an emphasis on peptides to be administered to lung Andrea Weiland, Explicat (Germany) |
Session 4: SPRIND: A quantum shift for new antiviral agents Chair: Armin Braun, Fraunhofer ITEM |
|
15:30 |
Jano Costard, Federal Agency for Disruptive Innovation SPRIND, Leipzig (Germany) |
15:45 |
iGUARD – translational development of antiviral RNAi Philippe Vollmer Barbosa, Fraunhofer ITEM |
16:00 |
Coffee break |
16:30 |
Programmable antiviral platform based on DNA nanotechnology – The VIRUS TRAP Alba Monferrer, Capsitec (Germany) |
16:45 |
RNA-drugs: Targeting viral RNA structures with small molecules Julia Weigand, Philipps-Universität Marburg (Germany) |
Poster session Chair: Thomas Tschernig, Saarland University (Germany) |
|
17:00 | Poster Session - Snacks & Drinks |
18:15 |
Guided tours to different non-clinical and clinical departments of Fraunhofer ITEM:
|
19:00 |
Awarding of poster prizes |
19:05 |
Outdoor barbecue at CRC Hannover |
21:30 |
Summary & conclusions day 1 Armin Braun, Fraunhofer ITEM |